Erratum to "Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings" [Eur J Cancer 136 (September 2020) 159−168]. (January 2021) - Castañón, Eduardo; Sanchez-Arraez, Alvaro; Alvarez-Manceñido, Felipe; Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto